Cargando…
Phase-Changing Glauber Salt Solution for Medical Applications in the 28–32 °C Interval
(1) Background: The field of medicine requires simple cooling materials. However, there is little knowledge documented about phase change materials (PCM) covering the range of 28 to 40 degrees Celsius, as needed for medical use. Induced mild hypothermia, started within 6 h after birth, is an emergin...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8658730/ https://www.ncbi.nlm.nih.gov/pubmed/34885261 http://dx.doi.org/10.3390/ma14237106 |
_version_ | 1784612799492653056 |
---|---|
author | Olson, Linus Lothian, Carina Ådén, Ulrika Lagercrantz, Hugo Robertson, Nicola J. Setterwall, Fredrik |
author_facet | Olson, Linus Lothian, Carina Ådén, Ulrika Lagercrantz, Hugo Robertson, Nicola J. Setterwall, Fredrik |
author_sort | Olson, Linus |
collection | PubMed |
description | (1) Background: The field of medicine requires simple cooling materials. However, there is little knowledge documented about phase change materials (PCM) covering the range of 28 to 40 degrees Celsius, as needed for medical use. Induced mild hypothermia, started within 6 h after birth, is an emerging therapy for reducing death and severe disabilities in asphyxiated infants. Currently, this hypothermia is accomplished with equipment that needs a power source and a liquid supply. Neonatal cooling is more frequent in low-resource settings, where ~1 million deaths are caused by birth-asphyxia. (2) Methods: A simple and safe cooling method suitable for medical application is needed for the 28 to 37.5 °C window. (3) Results: Using empirical experiments in which the ingredients in Glauber salt were changed, we studied the effects of temperature on material in the indicated temperature range. The examination, in a controlled manner, of different mixtures of NaCl, Na(2)SO(4) and water resulted in a better understanding of how the different mixtures act and how to compose salt solutions that can satisfy clinical cooling specifications. (4) Conclusions: Our Glauber salt solution is a clinically suited PCM in the temperature interval needed for the cooling of infants suffering from asphyxia. |
format | Online Article Text |
id | pubmed-8658730 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-86587302021-12-10 Phase-Changing Glauber Salt Solution for Medical Applications in the 28–32 °C Interval Olson, Linus Lothian, Carina Ådén, Ulrika Lagercrantz, Hugo Robertson, Nicola J. Setterwall, Fredrik Materials (Basel) Article (1) Background: The field of medicine requires simple cooling materials. However, there is little knowledge documented about phase change materials (PCM) covering the range of 28 to 40 degrees Celsius, as needed for medical use. Induced mild hypothermia, started within 6 h after birth, is an emerging therapy for reducing death and severe disabilities in asphyxiated infants. Currently, this hypothermia is accomplished with equipment that needs a power source and a liquid supply. Neonatal cooling is more frequent in low-resource settings, where ~1 million deaths are caused by birth-asphyxia. (2) Methods: A simple and safe cooling method suitable for medical application is needed for the 28 to 37.5 °C window. (3) Results: Using empirical experiments in which the ingredients in Glauber salt were changed, we studied the effects of temperature on material in the indicated temperature range. The examination, in a controlled manner, of different mixtures of NaCl, Na(2)SO(4) and water resulted in a better understanding of how the different mixtures act and how to compose salt solutions that can satisfy clinical cooling specifications. (4) Conclusions: Our Glauber salt solution is a clinically suited PCM in the temperature interval needed for the cooling of infants suffering from asphyxia. MDPI 2021-11-23 /pmc/articles/PMC8658730/ /pubmed/34885261 http://dx.doi.org/10.3390/ma14237106 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Olson, Linus Lothian, Carina Ådén, Ulrika Lagercrantz, Hugo Robertson, Nicola J. Setterwall, Fredrik Phase-Changing Glauber Salt Solution for Medical Applications in the 28–32 °C Interval |
title | Phase-Changing Glauber Salt Solution for Medical Applications in the 28–32 °C Interval |
title_full | Phase-Changing Glauber Salt Solution for Medical Applications in the 28–32 °C Interval |
title_fullStr | Phase-Changing Glauber Salt Solution for Medical Applications in the 28–32 °C Interval |
title_full_unstemmed | Phase-Changing Glauber Salt Solution for Medical Applications in the 28–32 °C Interval |
title_short | Phase-Changing Glauber Salt Solution for Medical Applications in the 28–32 °C Interval |
title_sort | phase-changing glauber salt solution for medical applications in the 28–32 °c interval |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8658730/ https://www.ncbi.nlm.nih.gov/pubmed/34885261 http://dx.doi.org/10.3390/ma14237106 |
work_keys_str_mv | AT olsonlinus phasechangingglaubersaltsolutionformedicalapplicationsinthe2832cinterval AT lothiancarina phasechangingglaubersaltsolutionformedicalapplicationsinthe2832cinterval AT adenulrika phasechangingglaubersaltsolutionformedicalapplicationsinthe2832cinterval AT lagercrantzhugo phasechangingglaubersaltsolutionformedicalapplicationsinthe2832cinterval AT robertsonnicolaj phasechangingglaubersaltsolutionformedicalapplicationsinthe2832cinterval AT setterwallfredrik phasechangingglaubersaltsolutionformedicalapplicationsinthe2832cinterval |